1,174
Views
7
CrossRef citations to date
0
Altmetric
Laboratory Study

Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease

, , &
Pages 400-404 | Received 23 Jan 2020, Accepted 13 Apr 2020, Published online: 29 Apr 2020

References

  • Lippi G, Banfi G, Church S, et al. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med. 2015;53(3):357–370.
  • Abdollahi A, Saffar H, Saffar H. Types and frequency of errors during different phases of testing at a clinical medical laboratory of a teaching hospital in Tehran, Iran. North Am J Med Sci. 2014;6(5):224–228.
  • Goswami B, Singh B, Chawla R, et al. Evaluation of errors in a clinical laboratory: a one-year experience. Clin Chem Lab Med. 2010;48(1):63–66.
  • Jones GRD, EFLM Task Finish Group – Analytical Performance Specifications for EQAS (TFG-APSEQA), Albarede S, Kesseler D, et al. Analytical performance specifications for external quality assessment - definitions and descriptions. Clin Chem Lab Med. 2017;55(7):949–955.
  • Guder WG. Preanalytical factors and their influence on analytical quality specifications. Scand J Clin Lab Invest. 1999;59(7):545–549.
  • Bonventre JV. Kidney injury molecule-1 (KIM1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009;24(11):3265–3268.
  • Andreucci M, Faga T, Pisani A, et al. The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice. Eur J Intern Med. 2017;39:1–8.
  • Castillo-Rodriguez E, Fernandez-Prado R, Martin-Cleary C, et al. Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease. Nephron. 2017;136(4):263–267.
  • Helmersson-Karlqvist J, Ärnlöv J, Carlsson AC, et al. Increased urinary cystatin C indicated higher risk of cardiovascular death in a community cohort. Atherosclerosis. 2014;234(1):108–113.
  • Bartoli E. Adverse effects of drugs on the kidney. Eur J Intern Med. 2016;28:1–8.
  • Heyman SN, Lieberthal W, Rogiers P, et al. Animal models of acute tubular necrosis. Curr Opin Crit Care. 2002;8(6):526–534.
  • Cantaluppi V, Quercia AD, Dellepiane S, et al. Interaction between systemic inflammation and renal tubular epithelial cells. Nephrol Dial Transplant. 2014;29(11):2004–2011.
  • Sohrabian A, Noraddin FH, Flodin M, et al. Particle enhanced turbidimetric immunoassay for the determination of urine cystatin C on Cobas c501. Clin Biochem. 2012;45(4-5):339–344.
  • Conti M, Moutereau S, Esmilaire L, et al. Should kidney tubular markers be adjusted for urine creatinine? The example of urinary cystatin C. Clin Chem Lab Med. 2009;47(12):1553–1556.
  • Helmersson-Karlqvist J, Ärnlöv J, Larsson A. Day-to-day variation of urinary NGAL and rational for creatinine correction. Clin Biochem. 2013;46(1-2):70–72.
  • Helmersson-Karlqvist J, Larsson A, Carlsson AC, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men. Atherosclerosis. 2013;227(2):408–413.
  • Helmersson-Karlqvist J, Arnlöv J, Carlsson AC, et al. Urinary KIM1, but not urinary cystatin C, should be corrected for urinary creatinine. Clin Biochem. 2016;49(15):1164–1166.
  • Björk J, Grubb A, Sterner G, et al. Revised equations for estimating glomerular filtration rate based on the Lund-Malmö Study cohort. Scand J Clin Lab Invest. 2011;71(3):232–239.
  • Kemperman FA, Krediet RT, Arisz L. Formula-derived prediction of the glomerular filtration rate from plasma creatinine concentration. Nephron. 2002;91(4):547–558.